Contraceptive implants and lactation

Contraception

Volumn 65, Issue 1, 2002, Pages 39-46

  Díaz, Soledad ^a  

^a Instituto Chileno de Medicina Reproductiva   (Chile)

Author keywords

Contraceptive implants; Elcometrine; Implanon; Lactation; Nestorone; Norplant

Indexed keywords

ELCOMETRINE; ETONOGESTREL; LEVONORGESTREL;

AMENORRHEA; ARTICLE; BONE DENSITY; BONE TURNOVER; BREAST FEEDING; BREAST MILK; CHILD GROWTH; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTRACEPTION; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG IMPLANT; DRUG RELEASE; DRUG SAFETY; DRUG SCREENING; DRUG USE; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; LACTATION; MILK LEVEL; POSTNATAL DEVELOPMENT; PUERPERIUM; WEANING;

BONE DENSITY; CHILD; CHILD DEVELOPMENT; CONTRACEPTIVE AGENTS, FEMALE; DRUG IMPLANTS; FEMALE; HEALTH STATUS; HUMANS; INFANT; INFANT, NEWBORN; LACTATION; MENSTRUATION; MILK, HUMAN; MOTHERS; POSTPARTUM PERIOD; TREATMENT OUTCOME;

EID: 0036183175     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(01)00295-5     Document Type: Article

References (46)

1. Contraceptive and health benefits of breastfeeding: A review of the recent evidence
2. Consensus statement on the use of breastfeeding as a family planning method
3. Contraceptive efficacy of lactational amenorrhea in urban Chilean women
4. Rethinking postpartum family planning
5. Contraception in lactating women
6. Effects of hormonal contraceptives on breast milk composition and infant growth
7. Fertility regulation in nursing women. IV. Long-term influence of a low-dose combined oral contraceptive initiated at day 30 postpartum upon lactation and infant growth
8. A review of the use of progestogen-only minipills for contraception during lactation
9. A multicenter clinical trial of a progestin-only oral contraceptive in lactating women
10. The progestin-only oral contraceptive - Its place in postpartum contraception
11. Exposure to contraceptive hormones through breast milk - Are there long-term health and behavioral consequences?
12. Fertility regulation in nursing women: VII. Influence of Norplant levonorgestrel implants upon lactation and infant growth
13. Influence of levonorgestrel contraceptive implants, Norplant, initiated early postpartum upon lactation and infant growth
14. Effect of Norplant on mothers and infants in the postpartum period
15. Progestogen-only contraceptives during lactation: I. Infant growth
16. Progestogen-only contraceptives during lactation: II. Infant development
17. Effect of early postpartum use of the contraceptive implants, Norplant, on the serum levels of immunoglobulins of the mothers and their breastfed infants
18. Pharmacodynamic effects of levonorgestrel (LNG) administered either orally or subdermally to early postpartum lactating mothers on the urinary levels of follicle stimulating hormone (FSH), luteinizing hormone (LH), and testosterone (T) in their breast-fed male infants
19. Fertility regulation in nursing women. IX. Contraceptive performance, duration of lactation, infant growth, and bleeding patterns during use of progesterone vaginal rings, progestin-only pills, Norplant implants, and Copper T 380-A intrauterine devices
20. Pregnancy and lactation as risk factors for subsequent bone loss and osteoporosis
21. Norplant implants and progesterone vaginal rings do not affect maternal bone turnover and density during lactation and after weaning
22. Effects of the Etonogestrel-realizing contraceptive implant (Implanon) on parameters of breastfeeding, compared to those of an IUD
23. The place of progesterone in human contraception
24. Milk and plasma concentrations of the progestin ST-1435 in women treated parenterally with ST-1435
25. Clinical trial with Nestorone subdermal contraceptive implants
26. Pharmacokinetics and bioavailability of ST-1435 administered by different routes
27. The progestin ST-1435 rapid metabolism in man
28. Contraceptive efficacy and clinical performance of Nestorone implants in postpartum women
29. Use of a single implant of Elcometrine (ST-1435), a nonorally active progestin, as a long acting contraceptive for postpartum nursing women
30. Levonorgestrel concentrations in maternal and infant serum during use of subdermal levonorgestrel contraceptive implants, Norplant, by nursing mothers
31. Transfer of levonorgestrel (LNG) administered through different drug delivery systems from the maternal circulation into the newborn infant's circulation via breast milk
32. Transfer of contraceptive steroids in milk of women using long-acting gestagens
33. Norethisterone concentration in breast milk and infant and maternal plasma during ethynodiol diacetate administration
34. Transfer of norethisterone (NET) and levonorgestrel (LNG) from a single tablet into the infant's circulation through the mother's milk
35. A comparison of the potencies and activities of progestogens used in contraceptives
36. The developing brain
37. The place of progesterone in human contraception
38. Mechanism of action of progesterone as contraceptive for lactating women
39. Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle
40. Role of endogenous opioids in reducing the frequency of pulsatile luteinizing hormone secretion induced by progesterone in normal women
41. Breastfeeding and fertility
42. A microcomputer software for analysis of menstrual diaries: The menstrual diary system